Our findings revealed a significant correlation between BCDG carriers, especially those with two-hit inactivation, a younger onset age, higher tumor mutation burden (TMB), and elevated Ki67 index compared to other germline carriers and noncarriers (Fig. 5e–g). This evidence concerns the gene MKI67 and neoplasm.